174 related articles for article (PubMed ID: 8532615)
1. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
Sánchez C
Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
[TBL] [Abstract][Full Text] [Related]
2. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics.
López-Rubalcava C; Saldívar A; Fernández-Guasti A
Pharmacol Biochem Behav; 1992 Oct; 43(2):433-40. PubMed ID: 1359576
[TBL] [Abstract][Full Text] [Related]
3. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
4. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
Hjorth S; Sharp T
J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
[TBL] [Abstract][Full Text] [Related]
5. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
6. Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?
Olsen CK; Hogg S; Lapiz MD
Behav Pharmacol; 2002 Jul; 13(4):261-9. PubMed ID: 12218506
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
Kleven MS; Koek W
J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
[TBL] [Abstract][Full Text] [Related]
8. The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice.
Sánchez C; Arnt J; Hyttel J; Moltzen EK
Psychopharmacology (Berl); 1993; 110(1-2):53-59. PubMed ID: 7870899
[TBL] [Abstract][Full Text] [Related]
9. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
[TBL] [Abstract][Full Text] [Related]
10. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
11. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Sánchez C; Hyttel J
Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
13. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
15. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
[TBL] [Abstract][Full Text] [Related]
17. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Borsini F; Ceci A; Bietti G; Donetti A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(1A) receptors play an important role in modulation of behavior of rats in a two-compartment black and white box.
Sánchez C
Behav Pharmacol; 1996 Dec; 7(8):788-797. PubMed ID: 11224473
[TBL] [Abstract][Full Text] [Related]
19. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
20. Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.
Verheij MM; Veenvliet JV; Groot Kormelink T; Steenhof M; Cools AR
Psychopharmacology (Berl); 2009 Aug; 205(3):441-55. PubMed ID: 19434397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
